Toronto, Canada — The announcement linking the use of paracetamol, commonly known as Tylenol, during pregnancy to autism has jolted parents and advocates in the autism community. Christina Collura, a mother of two, is among those whose thoughts spiraled into self-doubt as she recalled the medication’s availability during her pregnancies. Collura’s 12-year-old son, Luca, was diagnosed with autism at the age of three, and she confesses that the possibility of having caused his condition through medication use weighs heavily on her mind.

Following President Donald Trump’s statement, Collura witnessed a wave of anxiety sweep through fellow parents as they questioned their own choices during pregnancy. “So many moms were reflecting, saying, ‘Did you take Tylenol?'” she noted, emphasizing her resolve to reject such harmful speculation. The prevalent narrative, however, does not align with the consensus among medical experts, who maintain that no singular cause of autism has been established and continue to endorse paracetamol as a safe option for managing pain in expectant mothers.

Collura takes particular issue with the administration’s portrayal of autism as a “horrible crisis,” a label she believes misrepresents the reality of life with autism. “I’ve never viewed my family dynamic as a disaster,” she explained, countering the negative framing while emphasizing that any challenges faced are part of a broader spectrum of life. “To imply that children with autism create pandemonium is heart-wrenching,” she added.

Zoe Gross, an advocate with the Autistic Self Advocacy Network, expressed alarm at the implications of Trump’s comments. For many within the autistic community, the assertion that autism should be treated as a problem to mitigate is deeply personal and offensive. Gross called for the removal of U.S. Health Secretary Robert Kennedy Jr. following his endorsement of discredited claims linking vaccines to autism, further compounding community fears fueled by the administration’s rhetoric.

On Monday, Trump and Kennedy advised healthcare providers to exercise caution when prescribing acetaminophen to pregnant women, citing contentious and largely unsubstantiated connections to autism. Health professionals have responded strongly, underscoring the need for accurate information surrounding the medication and emphasizing its safety for pregnant women, urging against unfounded fears.

Collura remembers taking Tylenol only once during her pregnancies but noted that her anxiety is rooted in the fear of what might have been. “It’s the self-doubt that creates a spiral of anxiety,” she remarked, detailing her journey navigating Luca’s diagnosis. Her perseverance shone through when doctors predicted he might never speak, yet she celebrated his progress as he found his voice before his seventh birthday.

As a Toronto school teacher, Collura stands witness to the evolving understanding of autism in educational settings. She founded Creative Beginning to develop inclusive learning resources that foster acceptance and understanding among children. She argues that the rise in autism diagnoses reflects growing awareness and improved detection rather than an epidemic, insisting that a shift in perspective could lead to greater acceptance within society.

In response to the administration’s statements, the Department of Health and Human Services referenced the increase in autism diagnoses among children born in recent years, noting that about 3% of children born in 2014 received an autism diagnosis – a stark rise from previous decades. Meanwhile, the U.S. Food and Drug Administration announced plans to amend paracetamol labels and guide physicians to prescribe the lowest effective doses as needed during pregnancy.

Advocacy groups like Autism Speaks urge the administration to focus its efforts on innovative research aimed at enhancing the quality of life for those with autism rather than revisiting already debunked claims. Gross emphasized the importance of supporting practical needs, such as communication tools and service improvements, suggesting that a shift in approach could facilitate a more supportive environment for individuals with autism.

Ultimately, leaders in the autism community are calling for a narrative that embraces the diversity of experiences linked to autism, shedding light on opportunities for enhancement rather than framing the condition as a burden. “It’s newly recognized, not new,” Gross concluded, presenting a hopeful vision that augurs acceptance rather than rejection.